- 全部删除
您的购物车当前为空
Muraglitazar (BMS-298585) 是一种 PPAR α/γ的双激动剂,用于治疗2型糖尿病及相关血脂异常。Muraglitazar 对人 PPARα (EC50 = 320 nM)和 PPARγ(EC50 = 110 nM)具有较强的体外活性。

Muraglitazar (BMS-298585) 是一种 PPAR α/γ的双激动剂,用于治疗2型糖尿病及相关血脂异常。Muraglitazar 对人 PPARα (EC50 = 320 nM)和 PPARγ(EC50 = 110 nM)具有较强的体外活性。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 1,960 | In stock | |
| 5 mg | ¥ 4,830 | In stock | |
| 10 mg | ¥ 6,890 | In stock | |
| 25 mg | ¥ 9,870 | In stock | |
| 50 mg | ¥ 13,800 | In stock | |
| 100 mg | ¥ 18,600 | In stock | |
| 500 mg | ¥ 37,300 | In stock |
Muraglitazar 相关产品
| 产品描述 | Muraglitazar (BMS-298585) is a PPAR α/γ dual agonist for the treatment of type 2 diabetes and associated dyslipidemia. Muraglitazar shows potent activity in vitro at human PPARα and PPARγ with EC50 of 320 nM and 110 nM respectively. |
| 靶点活性 | PPARγ (HEK293 cells):0.04 μM (EC50), PPARα:0.42 μM, PPARγ:110 nM (EC50), PPARγ:0.14 μM, PPARα (HEK293 cells):1.41 μM (EC50), PPARα:320 nM (EC50) |
| 别名 | 莫格列地, Pargluva, BMS-298585 |
| 分子量 | 516.54 |
| 分子式 | C29H28N2O7 |
| CAS No. | 331741-94-7 |
| Smiles | C(COC1=CC=C(CN(C(OC2=CC=C(OC)C=C2)=O)CC(O)=O)C=C1)C=3N=C(OC3C)C4=CC=CC=C4 |
| 密度 | 1.274g/cm3 |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 128.8 mg/mL (249.35 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容